Want to see HK:0255 full AI Analyst Report?
0255 Stock Chart & Stats
HK$1.65
HK$0.04(3.51%)
At close: 4:00 PM EST
HK$1.65
HK$0.04(3.51%)
Day’s Range― - ―
52-Week RangeHK$1.33 - HK$1.98
Previous CloseN/A
Volume86.00K
Average Volume (3M)24.39K
Market Cap
HK$941.50M
Enterprise ValueHK$253.26
Total Cash (Recent Filing)HK$649.71M
Total Debt (Recent Filing)HK$2.79M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Mar 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield13.38%
Share Statistics
EPS (TTM)-0.05
Shares Outstanding634,007,300
10 Day Avg. Volume14,200
30 Day Avg. Volume24,392
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.70
Price to Sales (P/S)0.82
P/FCF Ratio6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet (low Leverage)Extremely low leverage gives the company durable financial flexibility: it lowers solvency risk, preserves borrowing capacity, and allows management to fund operations, capex or working-capital needs while executing turnaround measures over the next several months.
Resilient Operating Cash FlowConsistent positive operating cash flow, and recent positive free cash flow, indicate underlying cash generation despite accounting losses. This provides a runway for operations, supports necessary capex or distribution choices, and reduces near-term liquidity pressure.
Essential Supplier To Manufacturing ChainsThe company supplies critical mould-base components with recurring demand across multiple manufacturing sectors. This structural demand and repeat purchasing create a stable baseline revenue opportunity and supports long-term customer relationships and order visibility.
Bears Say
Three Years Of Net LossesSustained net losses erode retained earnings and limit financial options: they can constrain reinvestment, pressure dividend sustainability, and force cost-cutting or asset sales if profitability isn't restored within a medium-term horizon.
Revenue Contraction ResumingRenewed top-line decline hurts fixed-cost absorption and margin leverage in a capital-intensive goods business. If contraction persists, it will intensify margin pressure, reduce scale advantages, and complicate recovery plans over the next several quarters.
Inconsistent Free Cash FlowAn uneven FCF track record increases funding and forecasting risk: intermittent negative FCF limits discretionary investment, can necessitate external financing during downturns, and signals that cash strength may not be fully reliable long-term.
Lung Kee (Bermuda) Holdings Limited News
0255 FAQ
What was Lung Kee (Bermuda) Holdings Limited’s price range in the past 12 months?
Lung Kee (Bermuda) Holdings Limited lowest stock price was HK$1.33 and its highest was HK$1.98 in the past 12 months.
What is Lung Kee (Bermuda) Holdings Limited’s market cap?
Lung Kee (Bermuda) Holdings Limited’s market cap is HK$941.50M.
When is Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date?
Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date is Mar 19, 2027 which is in 198 days.
How were Lung Kee (Bermuda) Holdings Limited’s earnings last quarter?
Lung Kee (Bermuda) Holdings Limited released its earnings results on Aug 21, 2026. The company reported -HK$0.016 earnings per share for the quarter.
Is Lung Kee (Bermuda) Holdings Limited overvalued?
According to Wall Street analysts Lung Kee (Bermuda) Holdings Limited’s price is currently Overvalued.
Does Lung Kee (Bermuda) Holdings Limited pay dividends?
Lung Kee (Bermuda) Holdings Limited pays a Annually dividend of HK$0.08 which represents an annual dividend yield of 13.38%. See more information on Lung Kee (Bermuda) Holdings Limited dividends here
What is Lung Kee (Bermuda) Holdings Limited’s EPS estimate?
Lung Kee (Bermuda) Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lung Kee (Bermuda) Holdings Limited have?
Lung Kee (Bermuda) Holdings Limited has 634,007,300 shares outstanding.
What happened to Lung Kee (Bermuda) Holdings Limited’s price movement after its last earnings report?
Lung Kee (Bermuda) Holdings Limited reported an EPS of -HK$0.016 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lung Kee (Bermuda) Holdings Limited?
Currently, no hedge funds are holding shares in HK:0255
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lung Kee (Bermuda) Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
95.35%
12-Months-Change
Fundamentals
Return on Equity
13.38%
Trailing 12-Months
Asset Growth
-6.81%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Lung Kee (Bermuda) Holdings Limited
Lung Kee Group Holdings Limited, an investment holding company, manufactures and markets mould bases and related products in the People's Republic of China and internationally. The company also engages in the property investment and corporate management activities. The company was formerly known as Lung Kee (Bermuda) Holdings Limited and changed its name to Lung Kee Group Holdings Limited in June 2024. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee Group Holdings Limited is a subsidiary of Pan Island Investments Limited.
Technical Analysis
Ka Shui International Holdings Limited
―
Eva Precision Industrial Holdings Limited
―
IPE Group Limited
―
KFM Kingdom Holdings Ltd.
―
WK Group (Holdings) Limited
―